An arthritis drug could help Type 1 diabetes sufferers live longer
Thousands of people with Type 1 diabetes could see their lives extended by a drug usually used to treat arthritis sufferers.
Researchers hope that the drug, known as Abatacept, could be made available as a Type 1 diabetes treatment, after a two year long clinical trial of the drug saw progression of the disease halted. The scientists behind the trial are hoping that progression of Type 1 diabetes could be slowed for even longer than two years, though they say more research will be needed to determine this.
Advertisement
Hide AdAdvertisement
Hide Ad